SET and colorectal carcinoma: Moreover, significant lower miR-199b was significantly downregulated in the subgroup of patients with SET overexpression (Figure 1D), suggesting that altered expression miR-199b is a molecular mechanism that contributes to deregulate SET and PP2A activation status in CRC patients.